Department of Radiology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China.
Department of Graduate, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
J Cancer Res Ther. 2024 Aug 1;20(4):1186-1194. doi: 10.4103/jcrt.jcrt_79_24. Epub 2024 Aug 29.
To establish a prediction model of lung cancer classification by computed tomography (CT) radiomics with the serum tumor markers (STM) of lung cancer.
Two-hundred NSCLC patients were enrolled in our study. Clinical data including age, sex, and STM (squamous cell carcinoma [SCC], neuron-specific enolase [NSE], carcinoembryonic antigen [CEA], pro-gastrin-releasing peptide [PRO-GRP], and cytokeratin 19 fragment [cYFRA21-1]) were collected. A radiomics signature was generated from the training set using the least absolute shrinkage and selection operator (LASSO) algorithm. The risk factors were identified using multivariate logistic regression analysis, and a radiomics nomogram based on the radiomics signature and clinical features was constructed. The capability of the nomogram was evaluated using the training set and validated using the validation set. A correction curve and the Hosmer-Lemeshow test were used to evaluate the predictive performance of the radiomics model for the training and test sets.
Twenty-nine of 1234 radiomics parameters were screened as important factors for establishing the radiomics model. The training (area under the curve [AUC] = 0.925; 95% confidence interval [CI]: 0.885-0.966) and validation sets (AUC = 0.921; 95% CI: 0.854-0.989) showed that the CT radiomics signature, combined with STM, accurately predicted lung squamous cell carcinoma and lung adenocarcinoma. Moreover, the logistic regression model showed good performance based on the Hosmer-Lemeshow test in the training (P = 0.954) and test sets (P = 0.340). Good calibration curve consistency also indicated the good performance of the nomogram.
The combination of the CT radiomics signature and lung cancer STM performed well for the pathological classification of NSCLC. Compared with the radiomics signature method, the nomogram based on the radiomics signature and clinical factors had better performance for the differential diagnosis of NSCLC.
建立一种基于肺癌 CT 影像学组学与肺癌血清肿瘤标志物(STM)的肺癌分类预测模型。
本研究纳入了 200 名 NSCLC 患者。收集了临床数据,包括年龄、性别和 STM(鳞癌 [SCC]、神经元特异性烯醇化酶 [NSE]、癌胚抗原 [CEA]、胃泌素释放肽前体 [PRO-GRP]和细胞角蛋白 19 片段 [cYFRA21-1])。使用最小绝对值收缩和选择算子(LASSO)算法从训练集中生成一个影像学组学特征。使用多变量逻辑回归分析确定危险因素,并构建基于影像学组学特征和临床特征的影像学组学列线图。使用训练集评估列线图的性能,并使用验证集进行验证。使用校正曲线和 Hosmer-Lemeshow 检验评估影像学模型对训练集和测试集的预测性能。
从 1234 个影像学组学参数中筛选出 29 个重要因素用于建立影像学模型。训练集(曲线下面积 [AUC] = 0.925;95%置信区间 [CI]:0.885-0.966)和验证集(AUC = 0.921;95%CI:0.854-0.989)均表明,CT 影像学组学特征与 STM 联合可准确预测肺鳞癌和肺腺癌。此外,基于 Hosmer-Lemeshow 检验的逻辑回归模型在训练集(P = 0.954)和测试集(P = 0.340)中表现良好。良好的校准曲线一致性也表明了列线图的良好性能。
CT 影像学组学特征与肺癌 STM 联合应用于 NSCLC 的病理分类具有良好的性能。与影像学组学特征方法相比,基于影像学组学特征和临床因素的列线图在 NSCLC 的鉴别诊断中具有更好的性能。